GLP-2 (TZ) is a synthetic peptide, identified by the testing laboratory as “GLP TZ”, that belongs to the class of dual incretin receptor agonist research peptides. Compounds in this class are designed to act at two receptors at once: the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor, both class B G-protein-coupled receptors.
Research interest centres on how simultaneous GLP-1 and GIP receptor agonism compares with single-receptor activity. Laboratory work in this area looks at receptor binding and selectivity, cAMP signalling in receptor-expressing cell lines, and glucose-dependent insulin secretion in cultured pancreatic beta-cell models.
Each vial contains 20 mg or 30 mg of GLP-2 (TZ) (select a size above) as a lyophilized powder. Reconstitute with bacteriostatic water (sold separately) before laboratory use. The COA & Testing tab lists the tested batch, with links to verify it on COA Coalition and with the laboratory.
Verify on COA Coalition
